Antitumor activity of TAK-788 in NSCLC with EGFR exon 20 insertions. Janne, P. A., Neal, J. W., Camidge, D., Spira, A. I., Piotrowska, Z., Horn, L., Costa, D., Tsao, A. S., Patel, J. D., Gadgeel, S. M., Bazhenova, L., Zhu, V., West, H., Vincent, S., Zhu, J., Li, S., Riely, G. J. AMER SOC CLINICAL ONCOLOGY. 2019

View details for Web of Science ID 000487345806452